Hetero Lab Gets CDSCO Panel Nod To Study Pregabalin, Polmacoxib FDC tablet Dr. Divya Colin24 July 2023 6:00 PM ISTNew Delhi: The drug major Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Hetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible Tablet Dr. Divya Colin17 July 2023 6:00 PM ISTNew Delhi: Stating that the decision to waive off the clinical trial will be taken after a review of the Bioequivalence study report, the Subject...
Conduct bioequivalence Study of Elagolix tablets: CDSCO panel tells Hetero Labs Dr. Divya Colin16 July 2023 5:30 PM ISTNew Delhi: In response to the proposal presented by the drug major Hetero Labs to manufacture and market Elagolix tablet 150mg and 200mg, the Subject...
Exclude patients with significant cardiovascular diseases: CDSCO panel tells Hetero Labs on Polmacoxib, Paracetamol FDC Dr. Divya Colin23 Jun 2023 5:41 PM ISTNew Delhi: With the condition to exclude patients with significant cardiovascular diseases from the trial, the Subject Expert Committee (SEC)...
Present revised Phase III CT protocol : CDSCO Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin6 March 2023 6:00 PM ISTNew Delhi: Granting permission to conduct the bioequivalence (BE) study for antidiabetic fixed dose combination (FDC) of Sitagliptin phosphate...
Meet 52 richest Indians in Pharma Healthcare domain Farhat Nasim21 Sept 2022 7:33 PM ISTNew Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...
NPPA fixes retail prices of 37 formulations, including Sitagliptin- Metformin combinations Ruchika Sharma17 Sept 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 37 formulations including those...
Gilead Sciences settles patent disputes with Lupin, Cipla and 3 others over HIV, Hepatitis B drugs generic versions Ruchika Sharma16 Sept 2022 5:28 PM ISTThe generic drugmakers argued that the patents were invalid and unenforceable. They said in an August court filing that Gilead's patents covered...
NPPA fixes price of 84 formulations, revises 1 Ruchika Sharma13 May 2022 3:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 84 formulations and has...
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
33 drug samples fail to clear CDSCO test, 2 declared misbranded Susmita Roy23 Jan 2022 1:15 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 33...
New toxic drug impurities detected in some heart pills in US: Bloomberg Ruchika Sharma15 Oct 2021 9:15 AM ISTNew Delhi: Over the past three years, millions of blood pressure pills that contain a probable carcinogen have been recalled around the world. As...
